Protalix BioTherapeutics Other Current Assets

As of the most recent data (March 2026), PLX shows a other current assets of $1.1M. That compares with $17M in the prior-year period — down 93.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PLX's other current assets is now $1.1M (was $17M) — a 93.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Protalix BioTherapeutics is outperforming or lagging.

Tracking PLX's other current assets over time shows whether Protalix BioTherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $17M in the prior-year period — down 93.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Protalix BioTherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.1M) with ownership activity and broader fundamentals.

Protalix BioTherapeutics's other current assets is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.